Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Avandia rosiglitazone endocrine data

Lancet published a meta-analysis of diabetes drugs Avandia rosiglitazone from GSK and Actos pioglitazone from Takeda Pharmaceutical Co. Ltd. (Tokyo:4502, Osaka, Japan) and Eli Lilly and Co. (LLY, Indianapolis, Ind.). The analysis, which looked

Read the full 343 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE